These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9749441)

  • 1. Therapeutic equivalence investigations: statistical considerations.
    Röhmel J
    Stat Med; 1998 Aug 15-30; 17(15-16):1703-14. PubMed ID: 9749441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'.
    Liberati A; D'Amico R
    Int J Epidemiol; 2010 Dec; 39(6):1582-3. PubMed ID: 21113051
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for assessing noninferiority with censored data.
    Freitag G
    Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.
    Parienti JJ; Verdon R; Massari V
    BMC Med Res Methodol; 2006 Sep; 6():46. PubMed ID: 16987409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reflections on some methodological errors in the evaluation of drugs. Ten years experience at the National Marketing Authorization Commission].
    Bouvenot G
    Bull Acad Natl Med; 2001; 185(3):583-90; discussion 590-2. PubMed ID: 11501265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 14. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General design issues in efficacy, equivalency and superiority trials.
    Fleiss JL
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):306-13; discussion 323-7. PubMed ID: 1507018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo in the investigation of psychotropic drugs, especially antidepressants.
    Puzyński S
    Sci Eng Ethics; 2004 Jan; 10(1):135-42. PubMed ID: 14986779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General issues in efficacy, equivalency, and superiority trials: clinical considerations.
    Listgarten MA
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):314-9. PubMed ID: 1507019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing equivalence by showing that a specified percentage of the effect of the active control over placebo is maintained.
    Holmgren EB
    J Biopharm Stat; 1999 Nov; 9(4):651-9. PubMed ID: 10576409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC
    Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.